524322 KABRADG

Kabra Drugs Share Price

 

 

Start SIP in KABRADG

Start SIP
Kabra Drugs live price: ₹26.1. It opened at ₹27 vs previous close ₹26; intraday high/low: ₹27/₹25. The 50 & 200 DMA stand at ₹28.69/₹23.39.

Kabra Drugs Performance

  • Today's Low
  • ₹25
  • Today's High
  • ₹27
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹36
  • Open Price₹27
  • Previous Close₹26
  • Volume15,752
  • 50 DMA₹28.69
  • 100 DMA₹27.36
  • 200 DMA₹23.39

Investment Returns

  • Over 1 Month -14.48%
  • Over 3 Month -18.18%
  • Over 6 Month + 55.26%
  • Over 1 Year + 135.56%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 62
  • P/B Ratio
  • 2.2
  • Average True Range
  • 1.81
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.01
  • RSI
  • 36.61
  • MFI
  • 12.03

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹26.10
+ 0.3 (1.16%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹27.76
  • 50 Day
  • ₹28.69
  • 100 Day
  • ₹27.36
  • 200 Day
  • ₹23.39

Resistance and Support

25.39 Pivot Speed
  • R3 27.43
  • R2 26.61
  • R1 26.21
  • S1 24.99
  • S2 24.17
  • S3 23.77

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-07 Others Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters.
2026-02-13 Quarterly Results
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results
2025-10-08 Others Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
91.43%
8.57%

Kabra Drugs FAQs

Kabra Drugs share price is ₹26 As on 02 April, 2026 | 13:30

The Market Cap of Kabra Drugs is ₹61.9 Cr As on 02 April, 2026 | 13:30

The P/E ratio of Kabra Drugs is 14.4 As on 02 April, 2026 | 13:30

The PB ratio of Kabra Drugs is 2.2 As on 02 April, 2026 | 13:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23